Uttenthal, B.
62  results:
Search for persons X
?
2

Outcomes in patients with EBV+ PTLD treated with allogeneic..:

Choquet, S. ; Clark, A. ; Renard, C....
Hematological Oncology.  41 (2023)  S2 - p. 523-524 , 2023
 
?
3

CAR T in patients with large B‐cell lymphoma not fit for au..:

Kuhnl, A. ; Kirkwood, A. A. ; Roddie, C....
British Journal of Haematology.  202 (2023)  1 - p. 65-73 , 2023
 
?
 
?
5

Improved outcomes of large B‐cell lymphoma patients treated..:

Boyle, S. ; Roddie, C. ; O'Reilly, M....
British Journal of Haematology.  204 (2023)  2 - p. 507-513 , 2023
 
?
 
?
11

Advanced Hodgkin lymphoma in the east of England cancer net..:

Russell, J. ; Collins, A. ; Fowler, A....
Hematological Oncology.  35 (2017)  S2 - p. 318-319 , 2017
 
?
13

The JAK2V617F tyrosine kinase mutation identifies clinicall..:

GOULDING, C. ; UTTENTHAL, B. ; FORONI, L....
International Journal of Laboratory Hematology.  30 (2008)  5 - p. 415-419 , 2008
 
?
14

Safety and efficacy of autologous haematopoietic stem-cell ..:

Lindsay, J.O ; Hind, D ; Swaby, E...
https://eprints.whiterose.ac.uk/209060/3/1-s2.0-S2468125323004600-main.pdf.  , 2024
 
?
15

SARS-CoV-2-specific immune responses and clinical outcomes ..:

Barnes, E ; Goodyear, C.S ; Willicombe, M...
https://eprints.whiterose.ac.uk/201360/1/OCTAVE%20Nature%20Medicine%202023.pdf.  , 2023
 
1-15